article thumbnail

High-flying Fujifilm splashes $200M to beef up cell therapy capacity

Fierce Pharma

Fujifilm Corporation is spreading the wealth across two production units as the contract development and manufacturing organization (CDMO) juggernaut works through a cell therapy expansion. Fujifilm is dividing $200 million between a pair of subsidiaries.

article thumbnail

Novo Nordisk plans new $220M raw ingredients plant in Denmark

Fierce Pharma

Even as supplies of Novo Nordisk’s immensely popular GLP-1 drugs Ozempic and Wegovy start to stabilize, the Danish drugmaker continues to announce manufacturing and capacity upgrades at a rapid cli | Novo Nordisk Pharmatech, a unit that specializes in producing drug ingredients, is spending 1.5

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency.

article thumbnail

Medical Devices Are Evolving Toward Specialized Solutions

MedCity News

As medical devices evolve and become more sophisticated, we are seeing a trend toward specialization. Building customized solutions for specialized disease states creates a nimbleness to respond to new conditions and develop a platform uniquely suited for that condition. It will become commonplace to see devices that break new ground.

article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements. It is crucial to ensure supply chain risks are mitigated and have proactive strategies in place to address unforeseen challenges before they become an issue.

article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 132
article thumbnail

Fast-growing Adragos snaps up Swiss CDMO Baccinex, significantly expanding fill-finish firepower

Fierce Pharma

Now, the manufacturing arriviste—which was founded in 2020—is expanding its production network again with the acquisition of Switzerland's Baccinex, which specializes in fill and finish services.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.